tiprankstipranks
Gossamer Bio (GOSS)
NASDAQ:GOSS
US Market
GOSS
Gossamer Bio
RESEARCH TOOLSreports
Want to see GOSS full AI Analyst Report?

Gossamer Bio (GOSS) Stock News & Sentiment

1,391 Followers
Gossamer Bio Balances Seralutinib Promise With Cash Strain
Premium
Company Announcements
Gossamer Bio Balances Seralutinib Promise With Cash Strain
4d ago
GOSS
Gossamer Bio Restructures Debt and Advances Seralutinib Program
Premium
Company Announcements
Gossamer Bio Restructures Debt and Advances Seralutinib Program
6d ago
8K
GOSS
Options Volatility and Implied Earnings Moves Today, May 18, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 18, 2026
6d ago
NIU
BIDU
Gossamer Bio Investors File Securities Lawsuit Over Alleged Misstatements About Phase 3 Drug Trial 
Premium
Class Action
Gossamer Bio Investors File Securities Lawsuit Over Alleged Misstatements About Phase 3 Drug Trial 
1M ago
GOSS
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Analysts Allegedly Misled by Trial Claims: Levi & Korsinsky
Premium
Class Action
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Analysts Allegedly Misled by Trial Claims: Levi & Korsinsky
1M ago
GOSS
Gossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice
Premium
Company Announcements
Gossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice
1M ago
8K
GOSS
Gossamer Bio Lawsuit: Investors Allege Misleading Statements Ahead of Failed PAH Trial 
Premium
Class Action
Gossamer Bio Lawsuit: Investors Allege Misleading Statements Ahead of Failed PAH Trial 
2M ago
GOSS
More GOSS News >

GOSS News on the Web

Goldman Sachs suspends rating on Gossamer Bio
TipRanks News
Neutral
Gossamer Bio Balances Seralutinib Promise With Cash Strain
TipRanks News
Neutral
Guggenheim Reaffirms Their Hold Rating on Gossamer Bio (GOSS)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Gossamer Bio (GOSS) and Cullinan Management (CGEM)
TipRanks News
Neutral
Is Gossamer Bio (GOSS) Undervalued After Q1 2026? EPS -$0.20 (miss vs. -$0.18 est), Revenue $17. ...
GuruFocus News
Neutral
Gossamer Bio price target lowered to 28c from 30c at Barclays
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS) and Cullinan Management (CGEM)
TipRanks News
Bearish
Gossamer Bio Q1 Net Loss Expands; Eyes On The Pre-NDA Meeting With FDA For Seralutinib W In Mid-June
rttnews
Neutral

News Score - Last 7 Days

Very Negative
GOSS
Sector Average
Media Buzz
This Week17 articles
Weekly Average0.25 articles
News Sentiment
This Week17%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GOSS’s Media Buzz Sentiment?
17 articles about GOSS were published this week. In an average week, 0.25 articles are published.
    What is GOSS’s weekly average amount of articles?
    In an average week, 0.25 articles about GOSS are published.
      What is GOSS’s News Sentiment?
      17% of articles about GOSS were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week